Skip to Content

Aspen Pharmacare Holdings Ltd APNHF

Morningstar Rating
$12.25 +0.25 (2.04%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

APNHF is trading at a 639% premium.
Price
$12.25
Fair Value
$51.36
Uncertainty
High
1-Star Price
$84.49
5-Star Price
$28.73
Economic Moat
Wzcn
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if APNHF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$12.00
Day Range
$12.2512.25
52-Week Range
$9.2012.25
Bid/Ask
$11.86 / $13.42
Market Cap
$5.44 Bil
Volume/Avg
100 / 168

Key Statistics

Price/Earnings (Normalized)
14.51
Price/Sales
2.36
Dividend Yield (Trailing)
1.49%
Dividend Yield (Forward)
1.49%
Total Yield
1.54%

Company Profile

Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) – this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin – this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Mid Core
Total Number of Employees
9,161

Comparables

Valuation

Metric
APNHF
524742
237690
Price/Earnings (Normalized)
14.5125.6561.58
Price/Book Value
1.185.024.67
Price/Sales
2.366.896.13
Price/Cash Flow
13.3425.5725.62
Price/Earnings
APNHF
524742
237690

Financial Strength

Metric
APNHF
524742
237690
Quick Ratio
1.094.172.14
Current Ratio
1.925.723.86
Interest Coverage
3.77724.63
Quick Ratio
APNHF
524742
237690

Profitability

Metric
APNHF
524742
237690
Return on Assets (Normalized)
5.10%18.88%4.57%
Return on Equity (Normalized)
8.14%21.99%8.04%
Return on Invested Capital (Normalized)
6.61%21.68%5.30%
Return on Assets
APNHF
524742
237690
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
JwybxvzzwzQty$83.5 Bil
Merck KGaA ADR
MKKGY
WxxfkcxscNkzpc$73.0 Bil
Haleon PLC ADR
HLN
TzkycbhQsh$39.3 Bil
Teva Pharmaceutical Industries Ltd ADR
TEVA
TtlyfyysMyph$19.6 Bil
Viatris Inc
VTRS
LbnmdwsvJfmw$13.5 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
QrjhhvwCnf$13.2 Bil
Catalent Inc
CTLT
PkpydjhQjkrg$10.5 Bil
Perrigo Co PLC
PRGO
NbhlppxTmw$3.7 Bil
Prestige Consumer Healthcare Inc
PBH
TsqmpvypXksllc$3.6 Bil
Curaleaf Holdings Inc
CURLF
KhzbvzzckRvw$3.2 Bil

Sponsor Center